RT Journal Article
SR Electronic
T1 Transcriptome and DNA methylome analysis of peripheral blood samples reveals incomplete restoration and transposable element activation after 3-month recovery of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.19.22274029
DO 10.1101/2022.04.19.22274029
A1 Yin, Ying
A1 Liu, Xiao-zhao
A1 Tian, Qing
A1 Fan, Yi-xian
A1 Ye, Zhen
A1 Meng, Tian-qing
A1 Wei, Gong-hong
A1 Xiong, Cheng-liang
A1 Li, Honggang
A1 He, Ximiao
A1 Zhou, Li-quan
YR 2022
UL http://medrxiv.org/content/early/2022/04/23/2022.04.19.22274029.abstract
AB Comprehensive analyses showed that SARS-CoV-2 infection caused COVID-19 and induced strong immune responses and sometimes severe illnesses. However, cellular features of recovered patients and long-term health consequences remain largely unexplored. In this study, we collected peripheral blood samples from recovered COVID-19 patients (average age of 35.7 years old) from Hubei province, China, 3 months after discharge; and carried out RNA-seq and whole-genome bisulfite sequencing (WGBS) to identify hallmarks of recovered COVID-19 patients. Our analyses showed significant changes both in expression and DNA methylation of genes and transposable elements (TEs) in recovered COVID-19 patients. We identified 639 misregulated genes and 18516 differentially methylated regions (DMRs) in total. Genes with aberrant expression and DMRs were found to be associated with immune responses and other related biological processes, implicating prolonged overreaction of the immune system in response to SARS-CoV-2 infection. Notably, a significant amount of TEs were aberrantly activated and TE activation was positively correlated with COVID-19 severity. Moreover, differentially methylated TEs may regulate adjacent gene expression as regulatory elements. Those identified transcriptomic and epigenomic signatures define and drive the features of recovered COVID-19 patients, helping determine the risks of long COVID-19, and providing guidance for clinical intervention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Key R&D Program of China [2018YFC1004500 and 2018YFC1004000], HUST COVID-19 Rapid Response Call [2020kfyXGYJ057], the National Natural Science Foundation of China [NSFC 31771661, 32000488], Hubei Province Natural Science Foundation [2020CFB817] and program for HUST Academic Frontier Youth Team.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The studies involving human participants were reviewed and approved by Ethics Committee for Clinical Research of Reproductive Medicine Center, Tongji Medical College, Huazhong University of Science and Technology. The patients/participants provided their written informed consent to participate in this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPublic RNA-seq data of peripheral blood samples from COVID-19 patients at incremental, complicated, and critical stages were downloaded from GEO database (GSE161777). Public RNA-seq data of mESCs with LINE1 knockdown were downloaded from GEO database (GSE100939). The bulk RNA-seq and WGBS data generated during this study is available in Genome Sequence Archive (GSA) for human data repository of National Genomics Data Center (BioProject No. PRJCA006301, https://ngdc.cncb.ac.cn/bioproject/browse/PRJCA006301). https://ngdc.cncb.ac.cn/bioproject/browse/PRJCA006301 WGBSwhole-genome bisulfite sequencingDMRdifferentially methylated regionTEstransposable elementsLINEslong interspersed nuclear elementsSINEsshort interspersed nuclear elementsLTRslong terminal repeatsDNAsDNA transposonsDEGsdifferentially expressed genesDETEsdifferentially expressed TEs